CDC AND FDA EXPANDS COVID-19 BIVALENT BOOSTER VACCINE ELIGIBILITY TO INCLUDE CHILDREN 5-11

www.cdc.gov/media/releases/2022/s1012-COVID-19-Vaccines.htmlCDC Expands Updated COVID-19 Vaccines to Include Children Ages 5 Through 11

FDA News Release: Coronavirus (Covid-19) Update:
FDA Authorizes Moderna and Pfizer-BioNTech Bivalent Covid-19 Vaccines for Use as a Booster Dose in Younder age groups